secwatch.observer — SEC 8-K summary
======================================

Issuer:     RenovoRx, Inc. (RNXT)
CIK:        0001574094
Form:       8-K
Filed at:   2022-09-19T23:59:59+00:00
Accession:  0001493152-22-026179
Event type: leadership
Sentiment:  positive
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RenovoRx appoints Angela Gill Nelms as COO; $400K salary, stock option grant
----------------------------------------------------------------------------

- Angela Gill Nelms appointed COO effective Sept 19, 2022; previously COO at Florence Healthcare.
- Annual base salary $400,000, discretionary bonus target 35%, option to purchase 274,230 shares.
- Severance: 50% salary outside change-in-control, 100% plus full equity vesting during change-in-control period.
- Company expects Phase 3 TIGeR-PaC interim analysis in Q4 2022; Nelms to oversee operations.
- Also reimbursed up to $20,000 moving expenses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1574094/000149315222026179/0001493152-22-026179-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1574094/000149315222026179/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-026179

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer